Gts Securities LLC Liquidia Corp Call Options Transaction History

Gts Securities LLC

  • $46.5 Billion
  • Q2 2024

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024
SELL
$11.96 - $15.71 $111,228 - $146,103
-9,300 Reduced 47.94%
10,100 $121,000
Q1 2024

May 15, 2024
SELL
$11.35 - $16.73 $175,925 - $259,315
-15,500 Reduced 44.41%
19,400 $286,000
Q4 2023

Feb 14, 2024
BUY
$5.77 - $12.19 $81,357 - $171,879
14,100 Added 67.79%
34,900 $419,000
Q3 2023

Nov 15, 2023
BUY
$6.27 - $8.15 $130,415 - $169,520
20,800 New
20,800 $131,000

Others Institutions Holding LQDA

# of Institutions
163
Shares Held
36M
Call Options Held
1.79M
Put Options Held
380K
View Full List

About Liquidia Corp

LQDA Quotes by TradingView
  • Ticker LQDA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 64,362,300
  • Market Cap $709M
  • Description
  • Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...
More about LQDA
Track This Portfolio

Track Gts Securities LLC Portfolio

Follow Gts Securities LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gts Securities LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gts Securities LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email